newsfilter
← Latest News
GlobeNewswire·

Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference

EQ

LA JOLLA, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (NASDAQ:EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that